Show Parent

February

Tiotropium in the management of chronic obstructive pulmonary disease Rees P.J. Eur Respir J 2002; 19: 205-206
A breakthrough in the functional evaluation of the inspiratory muscle pump Clanton T.L. Eur Respir J 2002; 19: 207-208
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Vincken W., van Noord J.A., Greefhorst A.P.M., Bantje Th.A., Kesten S., Korducki L., Cornelissen P.J.G. Eur Respir J 2002; 19: 209-216
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Casaburi R., Mahler D.A., Jones P.W., Wanner A., San Pedro G., ZuWallack R.L., Menjoge S.S., Serby C.W., Witek T. Eur Respir J 2002; 19: 217-224
Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema Iwasawa T., Kagei S., Gotoh T., Yoshiike Y., Matsushita K., Kurihara H., Saito K., Matsubara S. Eur Respir J 2002; 19: 225-231
A novel clinical test of respiratory muscle endurance Hart N., Hawkins P., Hamnegard C-H., Green M., Moxham J., Polkey M.I. Eur Respir J 2002; 19: 232-239
Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma van Schayck C.P., Bijl-Hofland I.D., Cloosterman S.G.M., Folgering H.T.M., van der Elshout F.J.J., Van Weel C. Eur Respir J 2002; 19: 240-245
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability Giraud V., Roche N. Eur Respir J 2002; 19: 246-251
European Community Respiratory Health Survey calibration project of dosimeter driving pressures Ward R.J., Ward C., Johns D.P., Skoric B., Abramson M., Walters E.H. Eur Respir J 2002; 19: 252-256
Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects Melis M., Siena L., Pace E., Gjomarkaj M., Profita M., Pirazzoli A., Todaro M., Stassi G., Bonsignore G., Vignola A.M. Eur Respir J 2002; 19: 257-266
Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae Gaede K.I., Wilke G., Brade L., Brade H., Schlaak M., Muller-Quernheim J. Eur Respir J 2002; 19: 267-274
Clinical significance of histological classification of idiopathic interstitial pneumonia Flaherty K.R., Toews G.B., Travis W.D., Colby T.V., Kazerooni E.A., Gross B.H., Jain A., Strawderman R.L., Paine R., Flint A., Lynch J.P., Martinez F.J. Eur Respir J 2002; 19: 275-283
Outgrown asthma does not mean no airways inflammation Warke T.J., Fitch P.S., Brown V., Taylor R., Lyons J.D.M., Ennis M., Shields M.D. Eur Respir J 2002; 19: 284-287
Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children Wong G.W.K., Li S.T., Hui D.S.C., Fok T.F., Zhong N.S., Chen Y.Z., Lai C.K.W. Eur Respir J 2002; 19: 288-293
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis App E.M., Baran D., Dab I., Malfroot A., Coffiner M., Vanderbist F., King M. Eur Respir J 2002; 19: 294-302
Once-daily tobramycin in the treatment of adult patients with cystic fibrosis Whitehead A., Conway S.P., Etherington C., Caldwell N.A., Setchfield N., Bogle S. Eur Respir J 2002; 19: 303-309
Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure Madden B.P., Kariyawasam H., Siddiqi A.J., Machin A., Pryor J.A., Hodson M.E. Eur Respir J 2002; 19: 310-313
Management of lower respiratory tract infections by French general practitioners: the AIR II study Raherison C., Peray P., Poirier R., Romand P., Grignet J-P., Arsac P., Taytard A., Daures J-P. Eur Respir J 2002; 19: 314-319
Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions Alegre J., Jufresa J., Segura R., Ferrer A., Armadans L., Aleman C., Marti R., Ruiz E., Fernandez de Sevi... T. Eur Respir J 2002; 19: 320-325
Bronchial bacterial colonization in patients with resectable lung carcinoma Ioanas M., Angrill J., Baldo X., Arancibia F., Gonzalez J., Bauer T., Canalis E., Torres A. Eur Respir J 2002; 19: 326-332
Mechanisms and markers of airway inflammation in cystic fibrosis De Rose V. Eur Respir J 2002; 19: 333-340
Respiratory viral infections as promoters of allergic sensitization and asthma in animal models Schwarze J., Gelfand E.W. Eur Respir J 2002; 19: 341-349
Chemokines, innate and adaptive immunity, and respiratory disease Sabroe I., Lloyd C.M., Whyte M.K.B., Dower S.K., Williams T.J., Pease J.E. Eur Respir J 2002; 19: 350-355
ERS/ATS statement on interventional pulmonology: Chairmen: C.T. Bolliger, P.N. Mathur Beamis J.F., Becker H.D., Cavaliere S., Colt H., Diaz-Jimenez J.P., Dumon J.F., Edell E., Kovitz K.L., Macha H.N., Mehta A.C., Marel M., Noppen M., Strausz J., Sutedja T.G. Eur Respir J 2002; 19: 356-373
Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient Spitzer E., Staab D., Hanke R., Wahn U., Grosse R. Eur Respir J 2002; 19: 374-376
Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate Merget R., Marczynski B., Chen Z., Remberger K., Raulf-Heimsoth M., Willroth P.O., Baur X. Eur Respir J 2002; 19: 377-380
Chlorine exposure and the upper respiratory tract Shusterman D., Solomon C., Balmes J., Blanc P. Eur Respir J 2002; 19: 381-383
Safety of formoterol Turbuhaler(R) at cumulative dose of 90 {micro}g in patients with acute bronchial obstruction. J. Malolepszy, G. Boszormenyi Nagy, O. Selroos, P. Larsson, R. Brander. Eur Respir J 2002; 19: 384